|
|
Article: Prenatal screening impacts cystic fibrosis prevalence in Brittany, France.
- Article from:
- Medical Devices & Surgical Technology Week
- Article date:
- October 12, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 OCT 12 - (NewsRx.com & NewsRx.net) -- Prenatal screening impacts cystic fibrosis prevalence in Brittany, France.
"Taking into account the situation of Brittany, a region of western France where cystic fibrosis (CF) is common and where a neonatal screening program was set up 14 years ago, the aim of this study was to determine the way in which the birth prevalence of CF has been influenced by the various public health strategies implemented in the region (neonatal screening, prenatal diagnosis, ultrasound examination and family testing)," according to researchers in France.
"This study used the results of the neonatal screening program, which enabled ...